GlassScriptPhysician profile
Joshua H Holstead
NPI 1629396460
$6,649.40
in general payments reported to CMS, 2019-2025
46 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $888 · 2021: $1,132 · 2022: $811 · 2023: $734 · 2024: $968 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,405 · Education: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,405.43 |
| Education | $451.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,606.65 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $580.93 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $545.59 | 2019-2024 | Xiaflex |
| Abbvie INC. | $513.26 | 2019-2025 | |
| Antares Pharma, INC. | $315.91 | 2019-2025 | Xyosted |
| Pfizer INC. | $290.36 | 2019-2024 | |
| Allergan, INC. | $245.44 | 2019-2022 | |
| Coloplast Corp | $235.98 | 2019-2024 | Speedicath |
| Janssen Biotech, INC. | $187.35 | 2021-2025 | Erleada, Tecvayli, Talvey |
| Bayer Healthcare Pharmaceuticals INC. | $186.56 | 2019-2025 | |
| Urogen Pharma, INC. | $177.63 | 2024-2025 | |
| Axonics, INC. | $148.51 | 2020-2024 | Axonics, Bulkamid |
| Blue Earth Diagnostics | $120.70 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $118.11 | 2019-2022 | |
| Richard Wolf Medical Instruments Corp. | $98.28 | 2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Holstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.